5 results  1 of 1 

1 What is the Best Choice for Urate-lowering Therapy for Korean?
Yun-Hong Cheon, Jung Soo Song
J Rheum Dis.2020;27(2):78-87.   Published online 2020 March 25     DOI: http://dx.doi.org/10.4078/jrd.2020.27.2.78
      
2 Comparison of Efficacy and Safety of Febuxostat in Gout Patients with Chronic Kidney Disease Stage 3 and Stage 4/5
Eeunyoung Ahn, Sunggun Lee, Han-Na Lee, Seung-Geun Lee, Min Wook So
J Rheum Dis.2019;26(2):118-123.   Published online 2019 April 30     DOI: http://dx.doi.org/10.4078/jrd.2019.26.2.118
   
3 Comparative Efficacy and Safety of Febuxostat and Allopurinol in the Treatment of Hyperuricemia: A Bayesian Network Meta-analysis
Gwan Gyu Song, Young Ho Lee
J Rheum Dis.2015;22(6):356-365.   Published online 2015 October 31     DOI: http://dx.doi.org/10.4078/jrd.2015.22.6.356
   
4 Four-Week Effects of Allopurinol and Febuxostat Treatments on Blood Pressure and Serum Creatinine Level in Gouty Men
Hyun Ah Kim, Young-Il Seo, Yeong W. Song
J Korean Med Sci.2014;29(8):1077-1081.   Published online 2014 July 30     DOI: http://dx.doi.org/10.3346/jkms.2014.29.8.1077
      
5 The Urate-lowering Efficacy and Safety of Febuxostat in Korean Patients with Gout
Sung Hwan Park, Yeong Wook Song, Won Park, Eun Mi Koh, Bin Yoo, Soo Kon Lee, Dae Hyun Yoo, Yun Jong Lee, Hyun Ah Kim, Hyo Jin Choi, Ho Youn Kim, Hyong Gi Jung
J Rheum Dis.2013;20(4):223-230.   Published online 2013 August 31     DOI: http://dx.doi.org/10.4078/jrd.2013.20.4.223
   

 1 of 1